Intraoperative fluorescence imaging market seen growing to $1.31 billion by 2030

The intraoperative fluorescence imaging market is projected to rise from $0.68 billion in 2025 to $1.31 billion by 2030, driven by demand for minimally invasive, precision surgery. North America led in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Intraoperative fluorescence imaging gives surgeons real-time visibility into blood vessels, tissues and tumors during operations. - The technology supports more precise surgery, which can improve patient safety and outcomes. - Market growth tracks broader demand for minimally invasive and precision procedures.

What happened: - The intraoperative fluorescence imaging market is projected to grow from $0.68 billion in 2025 to $0.77 billion in 2026. - The market is forecast to reach $1.31 billion by 2030. - The forecast implies a 14.0% CAGR from 2025 to 2026 and a 14.3% CAGR through 2030. - The Business Research Company published the market outlook on July 17, 2026. - The company also offered a free sample report and a full market report.

The details: - Historical growth was linked to limited real-time surgical visualization tools, high intraoperative complication rates, wider use of minimally invasive surgery, early dye-based angiography, and rising demand for precision oncology surgery. - Future growth is expected to come from AI-powered surgical imaging, more personalized and precision surgery, broader robotic-assisted procedures, advances in fluorescence contrast agents and more real-time imaging in hybrid operating rooms. - Expected trends include AI-assisted fluorescence image interpretation, wider use of image-guided surgery, better tumor margin detection, robotic-assisted fluorescence-guided operations and next-generation near-infrared contrast dyes. - Intraoperative fluorescence imaging uses fluorescent dyes and specialized cameras to highlight internal structures during procedures. - The technique helps surgeons distinguish healthy from diseased tissue, assess blood flow and perform complex cancer resections and reconstructive operations. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - The market analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook suggests fluorescence imaging is moving from a niche surgical aid toward a standard tool for precision-guided operations. - AI and robotics appear poised to deepen that shift by making image interpretation and surgical navigation more automated. - The regional split suggests mature adoption in North America and faster new demand in Asia-Pacific. - A March 2023 example from the British Association of Aesthetic Plastic Surgeons showed 31,057 cosmetic surgeries in the UK in 2022, up 102% from the prior year, underscoring the broader rise in procedures that favor real-time guidance.

What's next: - Adoption should accelerate as hospitals add AI-assisted imaging, robotic surgery workflows and hybrid operating room systems. - The report points to continued innovation in contrast dyes and image interpretation tools as the next competitive battleground. - Regional expansion in Asia-Pacific may become a key growth driver through 2030.

The bottom line: - Intraoperative fluorescence imaging is on a steep growth path because surgery is becoming more precise, less invasive and more dependent on real-time visual guidance.